By Lynn Yap | Board Advisor, Life Sciences Week 2025
“How did you go from Estée Lauder to life sciences?”
It’s a question I’ve been asked a few times, and it’s revealing.
It highlights how we tend to divide the world of work into silos: creative vs. technical, emotional vs. analytical, soft vs. scientific.
But here’s the truth I’ve discovered after two decades across consumer brands and early-stage tech:
Innovation — whether in skincare or AI diagnostics — depends on the same foundation: trust, clarity, and relevance to human behaviour.
At first glance, beauty and biotech may appear unrelated.
But look closer, and you’ll see a shared ambition: both seek to shape how people perceive themselves, make decisions, and engage with the world.
Where Worlds Intersect
My career has spanned global brands like Adidas, Avon, and Estée Lauder, where I led strategy, commercial innovation, and customer experience. I’ve also worked with digital platforms and health tech startups, helping them scale from zero to traction.
Today, I advise mission-driven founders and corporates building sustainable, human-centred growth models, especially those operating at the intersection of science, technology, and health.
As health tech becomes a critical pillar of the life sciences ecosystem — from AI to RNA — our success will depend not only on what we build, but how we deliver it.
Real-world adoption doesn’t happen in white papers or funding decks.
It happens in complexity, shaped by emotion, trust, and human context.
Three Lessons Health Tech Should Borrow from Consumer Brands
1. People Buy Belief Before They Buy Outcomes
In beauty and wellness, you’re not just selling a product — you’re selling a promise.
A serum might offer hydration, but what you’re selling is confidence.
A sneaker might enhance performance, but you’re affirming identity.
Health tech has traditionally leaned into its scientific backbone. But while clinical efficacy and regulatory compliance are essential, they aren’t enough to drive mass adoption.
People — whether clinicians, caregivers, or patients — need to believe in the product before they’ll use it.
That belief starts with:
- Clear messaging: Is it immediately obvious why this solution matters?
- Accessible language: Can non-experts understand its value?
- Emotional relevance: Does it speak to the fears, hopes, or pressures of the user?
In a crowded space where many products promise to “revolutionise” care, belief becomes a form of differentiation. And belief is built through clarity, empathy, and narrative.
2. Design Is Emotional — Not Just Functional
Too often, health tech designs with a compliance-first mindset.
But compliance isn’t the same as care.
And functionality isn’t the same as feeling supported.
In consumer-facing brands, we deeply considered how every interaction shaped emotion: the colour of a product, the tone of voice, the pacing of onboarding.
Design isn’t just about usability — it’s about how a product makes people feel.
Health tech teams must ask:
- How does this product feel during a moment of vulnerability?
- Does the user feel respected, informed, and in control?
- Are we reinforcing clarity, or cognitive overload?
When a caregiver opens an app at 2 am to check a loved one’s vitals, or when a clinician receives an AI-generated recommendation, that moment is emotional. Design that understands this is design that earns trust.
And this isn’t just about aesthetics — it’s a strategic choice.
Emotionally intelligent design leads to greater engagement, retention, and impact.
3. Consistency Builds Trust — and Inconsistency Breaks It
Trust doesn’t just come from what you say. It comes from how consistently you say it, show it, and reinforce it.
In consumer brands, this shows up as packaging, tone, and the customer journey.
In health tech, it shows up in product experience, marketing, partnerships, and data handling.
Inconsistency might look like:
- A beautifully branded femtech app paired with clunky onboarding
- A promise of privacy undermined by vague consent language
- A clinician dashboard that operates completely differently from the patient app
Small inconsistencies signal bigger misalignments — and invite doubt.
Internally, this means aligning brand, product, UX, and legal.
Externally, it means ensuring your narrative and your reality match across every stakeholder touchpoint.
The result? A cohesive, confident brand that clinicians can recommend, investors can trust, and patients can rely on.
Systems, Not Silos
These challenges — trust, design, alignment — are not just product decisions. They’re system design decisions.
Too often, teams operate in silos:
- Product optimises for delivery.
- Marketing optimises for engagement.
- Compliance optimises for safety.
- Funders optimise for velocity.
But what we need is coherence across intentions, incentives, and outcomes.
To achieve this, we need:
- Founders who lead with clarity of mission and user empathy
- Investors who value adoption metrics, not just speed to market
- Regulators who embrace partnership, not just policing
- Designers, scientists, and strategists working side by side
The strongest health tech products of the next decade will be born from collaboration, not compartmentalisation.
Innovation That Endures
The future of life sciences won’t be defined only by faster diagnostics or deeper data sets.
It will be defined by whether those innovations reach people and stay with them.
It will be shaped by:
- Products designed for real lives, not ideal workflows
- Tools built to earn trust, not just headlines
- Companies that centre people over pipelines
Evidence and empathy aren’t in conflict. They’re the foundation of enduring innovation.
Let’s Build That Future Together
If you’re working in AI diagnostics, women’s health, biotech, or digital care platforms, I invite you to bring the lens of belief, design, and trust into your strategy.
That’s what I’ll be exploring further at Life Sciences Week 2025, alongside scientists, founders, and investors building what comes next.
Let’s not just create health solutions that work.
Let’s create ones that connect.
About the Author
Lynn Yap is a Board Advisor to Life Sciences Week 2025 and the author of The Altruistic Capitalist. She advises startups, corporates, and founders on commercial strategy, ethical innovation, and long-term value creation.
Connect on LinkedIn and Email| Explore more at AltruisticCapitalist.com
